EUVIMEDEUVIMED entdecken
Crossref

The Relationship Between Estrogen/Progesterone Receptor and Expression of mTOR/pAkt Proteins and the Analysis of Prognosis in Breast Cancer

Sun Wook Han, Moon Soo Lee, Sung Yong Kim, Gil Ho Kang, Zi Sun Kim, Cheol Wan Lim, Ji Hyun Lee, Hyun Ju Lee, Mee-Hye Oh, Min Hyuk Lee

Journal of Breast Disease · 2013

DOI: 10.14449/jbd.2013.1.5 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Breast Disease, 2013. Verfasst von Sun Wook Han und 9 weiteren Autor:innen. Die Arbeit nennt 27 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

The phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin (mTOR) pathway is a critical signaling pathway downstream of the growth factor receptor tyrosine kinase that regulates cell growth and survival.Rapamycin, an inhibitor of the mTOR, possesses antitumor activity against many tumors including breast cancer, especially against estrogen receptor (ER) positive breast cancer cell lines.In this study, the expression of mTOR and pAkt in breast cancer, its association with ER/progesterone receptor (PR) and prognosis were examined.

Methods

Formalin fixed paraffin-embedded 170 cases of the breast cancer were immunohistochemically stained, using rabbit monoclonal antibody mTOR and rabbit monoclonal antibody pAkt.Based on this, the expression pattern of ER/PR and mTOR/pAkt were analyzed, and outcomes were also investigated.Results: mTOR expression was positive in 110 of 170 cases (64.7%) and pAkt expression was positive in 130 of 170 cases (76.5%).In correlation between clinicopathologic factors and mTOR/pAkt expression, mTOR expression was correlated with ER/PR positive and pAkt expression was correlated with age (> 65), postmenopause.But there is no statistically significant in correlation between survival and mTOR/pAkt expression.

Conclusion

The expression of pAkt was correlated with postmenopausal women and increased age, and we found the expression of ER/PR increased mTOR.The results provide a rationale basis for future clinical development of mTOR inhibitor combined ER inhibitor in breast cancer.Key Words: Breast neoplasms, Estrogen receptors, Progesterone receptors, Proto-oncogene proteins c-akt, TOR serine-threonine kinase 서 론 Mammalian target of rapamycin (mTOR)는 포유류의 세포 내에 서 세포 생존 및 성장을 촉진하는 다양한 신호 전달체계에서 발견 되는 세린/트레오닌 키나아제(serine/threonine kinase)의 일종으로 phosphoinositol 3'-kinase (PI3K)/Akt 경로를 하향 조절하는 단백질 이다[1,2].또한 mTOR가 활성화되면 40S 리보솜단백질인 p70 S6 ki-nase와 4E-binding protein-1 (4EBP1)

Zitieren

APA

Han, S. W., Lee, M. S., Kim, S. Y., Kang, G. H., Kim, Z. S., Lim, C. W., Lee, J. H., Lee, H. J., Oh, M., & Lee, M. H. (2013). The Relationship Between Estrogen/Progesterone Receptor and Expression of mTOR/pAkt Proteins and the Analysis of Prognosis in Breast Cancer. Journal of Breast Disease. https://doi.org/10.14449/jbd.2013.1.5

Vancouver

Han SW, Lee MS, Kim SY, Kang GH, Kim ZS, Lim CW, et al. The Relationship Between Estrogen/Progesterone Receptor and Expression of mTOR/pAkt Proteins and the Analysis of Prognosis in Breast Cancer. Journal of Breast Disease. 2013. doi:10.14449/jbd.2013.1.5

BibTeX
@article{Han2013,
  author = {Han, Sun Wook and Lee, Moon Soo and Kim, Sung Yong and Kang, Gil Ho and Kim, Zi Sun and Lim, Cheol Wan and Lee, Ji Hyun and Lee, Hyun Ju and Oh, Mee-Hye and Lee, Min Hyuk},
  title = {The Relationship Between Estrogen/Progesterone Receptor and Expression of mTOR/pAkt Proteins and the Analysis of Prognosis in Breast Cancer},
  journal = {Journal of Breast Disease},
  year = {2013},
  doi = {10.14449/jbd.2013.1.5}
}
Kostenlos starten →